CARLSBAD, Calif., July 6, 2017 /PRNewswire/ -- Qualigen, Inc., a privately owned company that provides rapid, easy to use,fully quantitative diagnostic testing solutions, announced today that its Board of Directors has elected Kurt H. Kruger to the Board, effective June 26, 2017.
Mr. Kruger has enjoyed
Mr. Kruger received a Sc.B. degree in Biomedical Engineering from Brown University, a Master's degree in Bioengineering from the University of Michigan and a business degree (S.M.) from the Sloan School at the Massachusetts Institute of Technology (MIT). He also completed the premedical post-baccalaureate program at Columbia University.
"We are indeed fortunate to have Kurt Kruger join our Board. Kurt has extensive knowledge of the healthcare industry, having worked in product development and then investment banking. We are honored that Mr. Kruger has agreed to serve on the Board for Qualigen," said Michael S. Poirier, Chairman of the Board.
About Qualigen, Inc.Qualigen, Inc. is a medical device company focused on the development, production and commercialization of innovative medical technologies, including its flagship FastPackŪ point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases. For more information, visit www.qualigeninc.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kurt-h-kruger-joins-qualigens-board-of-directors-300484315.html
SOURCE Qualigen, Inc.
Subscribe to our Free Newsletters!
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...
Bile duct cancer occurs either within the liver or the point where the bile ducts emerge from the ...
Xeroderma pigmentosum is a rare inherited condition marked by extreme sensitivity to sunlight and ...View All